Soft tissue Sarcoma

May 13, 2025

Eli Lilly’s ZEPBOUND Surpasses WEGOVY in SURMOUNT-5 Trial; Verastem Oncology Secures FDA Approval for AVMAPKI + FAKZYNJA in KRAS-Mutant Ovarian Cancer; Thermosome Gains Orphan Drug Designation for THE001; Beam Therapeutics Receives RMAT Status for BEAM-302 in AATD; Capsida Biotherapeutics Gets IND Clearance for STXBP1 Gene Therapy

Apr 12, 2022

BioXcel’s Agitation Drug Igalmi; FDA Approves Cysteine Hydrochloride Injection; Gilead’s Trodelvy; Alembic Pharma’s Topical Anesthetic Cream; Pfizer Acquires ReViral; Telix Buys Lilly’s Failed Cancer Drug Lartruvo

Mar 05, 2021

Rare Cancer Market: A Global Crusade on what is a ‘less common cancer’?

Mar 02, 2021

Evotec, Chinook Teams Up for CKD Therapy; HitGen & UPPTHERA in Drug Delivery Research; Artiva’s $120 M Coup of NK Cell Therapy; Junshi & AZ with Toripalimab in China

Mar 10, 2020

Soft Tissue Sarcoma Treatment Market: Present treatment approaches and Unmet Needs

Mar 06, 2020

Soft Tissue Sarcoma: A rare malignancy

Newsletter/Whitepaper